VIRX logo

Viracta Therapeutics Inc

VIRX

$0.93

+ $0.30 (48.47%) This month

Closed: 1 Mar 2024 21:00 US/Eastern

Key details

CEO

Dayton Misfeldt

Employees

36

Headquarters

South San Francisco, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About Viracta Therapeutics Inc

viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus, and will pursue opportunities to address other serious virus-associated disease.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG